Telo Genomics Corp.
TELO.V
TSX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 925.80K | 1.01M | 998.20K | 969.80K | 889.50K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.67M | 1.84M | 1.92M | 1.93M | 1.89M |
| Operating Income | -1.67M | -1.84M | -1.92M | -1.93M | -1.89M |
| Income Before Tax | -1.70M | -1.87M | -1.93M | -1.94M | -1.87M |
| Income Tax Expenses | -11.10K | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.68 | -1.87 | -1.93 | -1.94 | -1.87 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.68M | -1.87M | -1.93M | -1.94M | -1.87M |
| EBIT | -1.67M | -1.84M | -1.92M | -1.93M | -1.89M |
| EBITDA | -1.63M | -1.82M | -1.91M | -1.92M | -1.87M |
| EPS Basic | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Diluted | -0.03 | -0.03 | -0.03 | -0.03 | -0.03 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 401.22M | 400.81M | 377.15M | 351.33M | 322.96M |
| Average Diluted Shares Outstanding | 401.22M | 400.81M | 377.15M | 351.33M | 322.96M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |